Changeflow GovPing Healthcare Stent End Point Locations System
Routine Rule Added Final

Stent End Point Locations System

Favicon for changeflow.com USPTO Patent Grants - Diagnosis & Surgery (A61B)
Published
Detected
Email

Summary

USPTO granted Koninklijke Philips N.V. Patent US12599438B2 for a system and method for determining suitable end point locations for a stent using intraluminal imaging. The system includes processors configured to receive temporal sequences of intraluminal images from an imaging device and identify whether positions along a lumen represent suitable stent end points. The patent contains 19 claims.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

USPTO granted Patent US12599438B2 to Koninklijke Philips N.V. for a system utilizing intraluminal imaging to determine suitable end point locations for stents. The patent covers processors configured to receive temporal sequences of intraluminal images and evaluate whether specific positions along a lumen are suitable stent endpoints.

Affected parties including medical device manufacturers and healthcare providers should monitor this intellectual property development as it may influence product development strategies and technology licensing considerations in the intravascular imaging and stent placement sector.

What to do next

  1. Monitor for updates

Archived snapshot

Apr 14, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Grants

Determining end point locations for a stent

Grant US12599438B2 Kind: B2 Apr 14, 2026

Assignee

KONINKLIJKE PHILIPS N.V.

Inventors

Vincent Maurice André Auvray, Stéphane Allaire

Abstract

A system (100) for determining a suitability of positions along a lumen (110) as end point locations for a stent, includes one or more processors (120) configured to: receive (S110), from an intraluminal imaging device (130), a temporal sequence of intraluminal images (1401 . . . n) representing positions along the lumen (110), including at least a first intraluminal image (140i⊂1 . . . n); and identify (S120), whether or not the first intraluminal image (140i⊂1 . . . n) represents a suitable end point location for the stent.

CPC Classifications

A61B 6/469 A61B 6/463 A61B 6/504 A61B 6/5247 G06T 2207/10016 G06T 2207/20101 G06T 2207/30101

Filing Date

2022-04-06

Application No.

18286398

Claims

19

View original document →

Get daily alerts for USPTO Patent Grants - Diagnosis & Surgery (A61B)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 14th, 2026
Instrument
Rule
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
US12599438B2

Who this affects

Applies to
Medical device makers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Patent grant Medical device technology Intraluminal imaging systems
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Medical Devices Healthcare

Get alerts for this source

We'll email you when USPTO Patent Grants - Diagnosis & Surgery (A61B) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!